MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41591-025-03591-0

Медицинская библиотека · Nature medicine · 2025

mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trial.

Rudman Spergel Amanda K, Ananworanich Jintanat, Guo Ruiting, Deng Weiping, Carmona Lizbeth, Schaefers Kristin, Paila Yamuna D, Kandinov Boris, Eger Charles H, Sinkiewicz Melissa, Shao Sarah, Henry Carole, Shaw Christine A

СтатьяКлиническое исследование II фазыКлиническое исследование I фазыРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

A multicomponent vaccine targeting several seasonal respiratory pathogens may provide simultaneous protection in a single-injection regimen. We present interim (28 days) findings from a phase 1/2 study of an mRNA-based multicomponent vaccine (mRNA-1083), encoding seasonal influenza and SARS-CoV-2 antigens. Adults (18-79 years) were randomly assigned to receive different compositions of mRNA-1083 at varying dose levels on day 1. The primary study objectives were reactogenicity through 7 days and safety through 28 days postvaccination, and the secondary study objective was immunogenicity against vaccine-matched influenza and SARS-CoV-2 strains at day 29 assessed by hemagglutination inhibition and pseudovirus neutralization assays, respectively. The multicomponent mRNA-1083 vaccine was generally well-tolerated, with most solicited adverse reactions being Grade 1 or 2 in severity. The incidence of unsolicited adverse events was similar across vaccine groups. mRNA-1083 induced immune responses against influenza and SARS-CoV-2 that were, in general, similar to or higher than those achieved with licensed quadrivalent influenza (standard or high dose) and SARS-CoV-2 (bivalent mRNA-1273) vaccines. These data support ongoing phase 3 evaluation of the mRNA-1083 vaccine. ClinicalTrials.gov registration: NCT05827926 .

Для цитирования: Rudman Spergel Amanda K, Ananworanich Jintanat, Guo Ruiting, Deng Weiping, Carmona Lizbeth, Schaefers Kristin, Paila Yamuna D, Kandinov Boris, Eger Charles H, Sinkiewicz Melissa, Shao Sarah, Henry Carole, Shaw Christine A. mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trial.. Nature medicine. 2025. DOI: 10.1038/s41591-025-03591-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.